Thomas Pfisterer

Thomas Pfisterer

Director/Board Member at
InSphero AG

Net worth: 10 M $ as of 30/06/2026

44 year
Health Technology
Consumer Services
Consumer Non-Durables

Profile

Thomas Pfisterer currently works at InSphero AG, as Non-Executive Director, Lakewood-Amedex, Inc., as Director from 2022, Sermonix Pharmaceuticals LLC, as Director, Stade Français Paris SA, as Non-Executive Director, Imvax, Inc., as Non-Executive Director, and Bloom Diagnostics AG, as Director.
Mr. Pfisterer also formerly worked at ADC Therapeutics SA, as Non-Executive Director and WILD Flavors GmbH, as Head-Strategic Development from 2011 to 2015.
Mr. Pfisterer received his graduate degree from the University of Cambridge and undergraduate degree from the University of St. Gallen.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
15/05/2025 9,788,944 ( 7.7% ) 10 M $ 30/06/2026

Thomas Pfisterer active positions

CompaniesPositionStart
Director/Board Member -
Director/Board Member -
Director/Board Member -
Director/Board Member -
Director/Board Member -
Director/Board Member 25/01/2022

Former positions of Thomas Pfisterer

CompaniesPositionEnd
Corporate Officer/Principal 02/01/2015
ADC THERAPEUTICS SA Director/Board Member -
See the detail of Thomas Pfisterer's experience

Training of Thomas Pfisterer

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

14

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Consumer Services

Consumer Services

Health Technology

Consumer Non-Durables

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Technology Services

  1. Stock Market
  2. Insiders
  3. Thomas Pfisterer